Richard D. Francis, President and CEO of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 412,032 shares of the company's stock on March 3, 2026. The transactions, executed at an average price of $32.36 per share, amounted to approximately $13.33 million.
This sale by a top executive represents a significant divestment of shares. Insider sales can be driven by various factors including portfolio diversification, tax obligations, or pre-arranged trading plans and do not necessarily reflect a negative outlook on the company's future performance.
The sale occurred amidst other insider selling activity within TEVA, with multiple executives also reporting stock sales on the same day.